CardioDx
The developer has presented clinical results that provide a base for completing development of a multi-protein test kit and conducting a clinical trial in advance of FDA submission.
CardioDx Raises $20M; Inks Specimen Draw Agreement With Quest
The deal with Quest enables clinicians to order blood draws on patients through its facilities for testing with CardioDx's Corus CAD test.
- The data, presented at the American College of Cardiology meeting, showed that doctors referred only 4 percent of women with low Corus CAD scores for further cardiac evaluation.
CardioDx Withdraws IPO
In an SEC document, the company called current market conditions for an IPO unattractive.
CardioDx Raises $35M
The financing will go toward further commercialization of its Corus CAD test, as well as other genomics tests for coronary artery disease.
Apr 29, 2014
CardioDx 2013 Revenues Rise Sharply
Apr 9, 2014
Medison to Market CardioDx's Corus CAD in Israel
Nov 4, 2013
CardioDx Sets Price Range on Planned IPO
Oct 28, 2013
Awaiting IPO, CardioDx Q3 Revenues up Sharply
Oct 23, 2013
Oct 14, 2013
Cardiovascular MDx Firm CardioDx Files to Go Public
May 9, 2013
CAP Accredits CardioDx's Laboratory
Sep 26, 2012